Table 2.  . Patients with cancer and coronavirus disease-2019 infection – prognostic factors.

Variable	Dead patients (n = 9)	Alive patients (n = 16)	p-value
Age (years), mean (range)	74.44 ± 7.21 (64–84)	68.38 ± 10.16 (50–83)	0.02
Sex
– Male (%)	5/20 (25)	15/20 (75)	0.04
– Female (%)	4/5 (80)	1/5 (20)
Tumor site
– Breast (%)	2/2 (100)	0/2 (0)	0.02
– Gastroenteric (%)	0/6 (0)	6/6 (100)
– Genitourinary (%)	3/6 (50)	3/6 (50)
– Hematologic (%)	2/2 (100)	0/2 (0)
– Lung (%)	2/8 (25)	6/8 (75)
– Undefined (%)	0/1 (0)	1/1 (100)
CRP (mg/dl)	14.82 ± 7.54 (4.9–29)	9.33 ± 4.87 (3–17)	0.047
Treatment
– Lopinavir and ritonavir+ hydroxychloroquine (%)	3/10 (30)	7/10 (70)	0.12
– Darunavir and cobicistat + hydroxychloroquine (%)	2/10 (20)	8/10 (80)
– Hydroxychloroquine (%)	4/5 (80)	1/5 (20)

Note: Significant p-values reported in bold terms.